A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Withers, 1985, Biologic basis for altered fractionation schemes, Cancer, 55, 2086, 10.1002/1097-0142(19850501)55:9+<2086::AID-CNCR2820551409>3.0.CO;2-1

Ang, 1994, Principles and practices of oncology, PPO Updates, 4, 1

Ang, 1998, Altered fractionation trials in head and neck cancer, Semin Radiat Oncol, 8, 230, 10.1016/S1053-4296(98)80020-9

Marcial, 1987, Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality, Int J Radiat Oncol Biol Phys, 13, 41, 10.1016/0360-3016(87)90258-6

Cox, 1990, Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts, Int J Radiat Oncol Biol Phys, 18, 515, 10.1016/0360-3016(90)90054-N

Cox, 1991, ASTRO Plenary, Int J Radiat Oncol Biol Phys, 20, 1191, 10.1016/0360-3016(91)90227-U

Fu, 1995, Late effects of hyperfractionated radiotherapy for advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 32, 577, 10.1016/0360-3016(95)00080-I

Fu, 1995, Randomized Phase I/II trial of two variants of accelerated fractionation radiotherapy regimens for advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 32, 589, 10.1016/0360-3016(95)00078-D

Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial], Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C

Zelen, 1974, The randomization and stratification of patients to clinical trials, J Chronic Dis, 27, 365, 10.1016/0021-9681(74)90015-0

Dunnett, 1995, A multiple comparison procedure from comparing several treatments with a control, J Am Stat Assoc, 50, 1096, 10.1080/01621459.1955.10501294

Bristol, 1989, Designing clinical trials for two-sided multiple comparisons with a control, Control Clin Trials, 10, 142, 10.1016/0197-2456(89)90027-5

Lee, 1995, Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherpay plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas, Int J Radiat Oncol Biol Phys, 32, 567, 10.1016/0360-3016(95)00150-W

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

Mantel, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chem Rep, 5, 163

Kalbfleish JD, Prentice RL. The statistical analysis of failure times data. New York: John Wiley; 1980.

Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951

Wang, 1985, Twice-a-day radiation therapy for cancer of the head and neck, Cancer, 55, 2100, 10.1002/1097-0142(19850501)55:9+<2100::AID-CNCR2820551411>3.0.CO;2-A

Wang, 1986, Twice-a-day radiation therapy for supraglottic carcinoma, Int J Radiat Oncol Biol Phys, 12, 3, 10.1016/0360-3016(86)90407-4

Wang, 1988, Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes, Int J Radiat Oncol Biol Phys, 14, 1143, 10.1016/0360-3016(88)90390-2

Wang, 1989, Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx, Cancer, 63, 2461, 10.1002/1097-0142(19890615)63:12<2461::AID-CNCR2820631217>3.0.CO;2-#

Wang, 1997, Role of accelerated fractionated irradiation for supraglottic carcinoma, Cancer J Sci Am, 3, 88

Datta, 1989, Twice a day versus once a day radiation therapy in head and neck cancer, Int J Radiat Oncol Biol Phys, 17, 132, 10.1016/0360-3016(89)90665-2

Horiot, 1992, Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma, Radiother Oncol, 25, 231, 10.1016/0167-8140(92)90242-M

Sanchiz, 1990, Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer, Int J Radiat Oncol Biol Phys, 19, 1347, 10.1016/0360-3016(90)90342-H

Pinto, 1991, Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma, Int J Radiat Oncol Biol Phys, 21, 557, 10.1016/0360-3016(91)90670-Y

Ang KK, Trotti A, Garden AS; et al. Importance of overall time factor in postoperative radiotherapy. In: Shah JP, Johnson JT, editors. 4th International Conference on Head and Neck Cancer. Toronto, Canada: The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery; 1996. p. 231–235.

Awwad, 1992, Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer, Radiother Oncol, 25, 261, 10.1016/0167-8140(92)90245-P

Horiot, 1997, Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers, Radiother Oncol, 44, 111, 10.1016/S0167-8140(97)00079-0

Johnson, 1992, Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck, Cancer, 69, 2749, 10.1002/1097-0142(19920601)69:11<2749::AID-CNCR2820691120>3.0.CO;2-4

Overgaard, 1997, Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck, Int J Radiat Oncol Biol Phys, 39, 188, 10.1016/S0360-3016(97)80665-7

Saunders, 1996, Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer, Br J Cancer, 73, 1455, 10.1038/bjc.1996.276

Maciejewski, 1996, Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer, Radiother Oncol, 40, 137, 10.1016/0167-8140(96)01776-8

Jackson, 1997, A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer, Radiother Oncol, 43, 39, 10.1016/S0167-8140(97)01944-0

Kaanders, 1992, Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity, Int J Radiat Oncol Biol Phys, 24, 497, 10.1016/0360-3016(92)91065-U

Brizel, 1998, Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma, Semin Radiat Oncol, 8, 237, 10.1016/S1053-4296(98)80021-0

Trotti, 1997, Toxicity antagonists in cancer therapy, Curr Opin Oncol, 9, 569, 10.1097/00001622-199711000-00013

Eisbruch, 1998, Comprehensive irradiation of head and neck cancer using conformal multisegmental fields, Int J Radiat Oncol Biol Phys, 41, 559, 10.1016/S0360-3016(98)00082-0

Eisbruch, 1999, Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, Int J Radiat Oncol Biol Phys, 45, 577, 10.1016/S0360-3016(99)00247-3

Wu, 2000, The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers, Int J Radiat Oncol Biol Phys, 46, 195, 10.1016/S0360-3016(99)00304-1

Fu, 1997, Combined modality therapy for head and neck cancer, Oncology, 11, 1781

Wendt, 1998, Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer, J Clin Oncol, 16, 1318, 10.1200/JCO.1998.16.4.1318

Calais, 1999, Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [see comments], J Natl Cancer Inst, 91, 2081, 10.1093/jnci/91.24.2081

Wheeler RH, Spencer S, Buchsbaum D, Robert F. Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer. Curr Opin Oncol 1999;11:187–190.